JF
STOK icon

Jump Financial’s Stoke Therapeutics STOK Stock Holding History

Jump Financial’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.41M Buy
+104,350
New +$3.35M 0.03% 667
2024
Q3 		– Sell
-34,277
Closed -$463K – 2096
2024
Q2 		$463K Buy
+34,277
New +$463K 0.01% 1166
2023
Q1 		– Sell
-15,552
Closed -$144K – 2041
2022
Q4 		$144K Buy
15,552
+5,552
+56% +$57.7K 0.01% 1363
2022
Q3 		$128K Sell
10,000
-24,700
-71% -$394K 0.01% 1418
2022
Q2 		$458K Buy
34,700
+19,850
+134% +$302K 0.02% 895
2022
Q1 		$312K Buy
+14,850
New +$297K 0.01% 1051
2021
Q3 		– Sell
-10,200
Closed -$343K – 1485
2021
Q2 		$343K Buy
10,200
+1,266
+14% +$44.8K 0.03% 615
2021
Q1 		$347K Buy
+8,934
New +$509K 0.03% 556

Other funds holding STOK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jump Financial's STOK Position: Q2 2026 in Review

Jump Financial opened a new position in Stoke Therapeutics (STOK) in Q2 2026: 104,350 shares worth $3.41M. The stake represents 0.03% of the portfolio and ranks #667 among its holdings. This is a return to the name: Jump Financial previously reported a position in STOK as recently as Q2 2024.

Jump Financial first reported a position in STOK in Q1 2021 and has held it in 8 quarters since. 197 funds tracked by Wall St. Rank hold STOK as of Q2 2026.

  • Jump Financial held 104,350 shares of Stoke Therapeutics worth $3.41M as of Q2 2026.
  • Stoke Therapeutics was a new Jump Financial position in Q2 2026.
  • Stoke Therapeutics made up 0.03% of Jump Financial's portfolio in Q2 2026, its #667 holding.
  • Jump Financial first reported a position in Stoke Therapeutics in Q1 2021 and has held it in 8 quarters since.
  • 197 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.